Provided are diagnostic assays and method s of using the diagnostic assays for detecting and quantifying RGMa fragments in a sample. The methods may be used detection of the RGMa fragments to monitoring drug treatment and effectiveness of drug treatment in neurodegenerative diseases.
申请公布号
AU2015314240(A1)
申请公布日期
2017.02.09
申请号
AU20150314240
申请日期
2015.09.09
申请人
AbbVie Deutschland GmbH & Co. KG
发明人
Barghorn, Stefan;Muller, Berhard K.;Schmidt, Martin;Striebinger, Andreas